Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
Jairam R. Lingappa(University of Namur), Connie Celum(University of Washington), Glenda Gray(South African Medical Research Council), James Kiarie(World Health Organization), Katherine K. Thomas(University of Namur), Grace John Stewart(University of Namur), Carey Farquhar(University of Washington), Saidi Kapiga(University of Namur), David Coetzee(University of Namur), Amalia Magaret(University of Namur), Rachel Manongi(Christian Medical College, Vellore), Elizabeth A. Bukusi(University of California, San Francisco), Etienne Karita(Rwanda Biomedical Center), Elly Katabira(University of Namur), Nelly Mugo(University of Washington), Guy de Bruyn(University of Namur), Helen Rees(Institute of Mental Health), James McIntyre(Perinatal HIV Research Unit), Susan Allen(Emory University), William Kanweka(University of Namur), Anna Wald(University of Washington), Linda Barnes(University of Namur), Renée Ridzon(University of Namur), Lawrence Corey(Fred Hutch Cancer Center), Lara Kidoguchi, Jared M. Baeten(University of Washington), Edwin Were(University of Namur), Kayitesi Kayitenkore(University of Namur), Richard S. Wang(University of Washington), Bellington Vwalika(University of Namur), Andrew Mujugira(Makerere University), Craig R. Cohen(University of Namur), Joseph Makhema(University of Namur), Kenneth H. Fife(Indiana University – Purdue University Indianapolis), James P. Hughes(University of Namur), Mubiana Inambao(University of Namur), Sinéad Delany(University of Namur), Allan Ronald(University of Namur)
Cited by 150
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k